Open in interactive viewer → charts, metric popovers & call review

Montauk's Turkey Plant Stops Being a Construction Story and Becomes a Solvency Story

Q3 revenue rose 10.9% and RIN realizations jumped 12.7% — yet the stock fell 56% in eight sessions as “covenant” replaced “RIN price” in the company's vocabulary
MNTK · Earnings Call · 2026-11-16

The tell was in the words that vanished

Montauk Renewables reported a quarter that looked, on the top line, like steady progress: total revenue of $50.2 million, up 10.9% year over year, with revenue helped by 13.9 million RINs self-marketed (up 12.2%) at an average realized price of $2.58 versus $2.29 a year ago. The RIN index itself cooperated, averaging $2.47 in the quarter against $2.19. The commodity that has dominated this company's narrative for three years was, for once, not the villain. And yet operating income swung to a $1.0 million loss from a $4.4 million profit, adjusted EBITDA fell 20.6% to $10.2 million, net income dropped 58.9% to $2.1 million, and the equity fell roughly 56% in the eight trading sessions into the report. The reason is that the argument has moved off the RIN market entirely. Where prior quarters led with obligated-party purchasing behaviour and D3 index prices, this quarter's language is a different dialect altogether: a new senior credit facility, a binding term sheet with the lender, applicable financial covenants being stood still, and a menu of restructuring alternatives. CFO Kevin Van Asdalan barely buried the lede:

The non-binding term sheet contains terms to borrow additional debt and forbear and stand still certain debt requirements for a period of 12 months in the future, as without such amendment, we believe it is probable that we will not meet our existing debt covenant requirements through the 12 months following the issuance of these financial statements.

Kevin Van Asdalan, Chief Financial Officer · 2026-11-16
That is going-concern language on a company with a $167 million market capitalization and $155 million drawn on its revolver.

The $200 million project that needs a $15 million repair

Montauk's whole bull case has rested on Turkey, North Carolina — the Montauk Ag Renewables project that converts swine waste into electricity, RECs, biochar and biocrude. It has been "commissioning" for roughly a year. On the March call, the CFO promised the payoff: “With the commissioning of our North Carolina Turkey project in the second quarter of this year... there will be a significant uplift in EBITDA coming from that location.” — Kevin Van Asdalan, Chief Financial Officer · 2026-03-12 In May, the ramp was already contingent: “Our ramp throughout 2026 is contingent upon us getting caught up and meeting some internal expectations associated with our own farm installation related to feedstock collection.” — Kevin Van Asdalan, CFO or Financial Officer (inferred from discussing financial results) · 2026-05-07 Now the diagnosis is mechanical, and the price tag is explicit. CEO Sean McClain identified “two specific concerns limiting the commercial production volumes of the facility, those being the moisture control of our inlet feedstock and the preservation of syngas temperature from our reactors to our compression and power generation.” — Sean McClain, President · 2026-11-16 Fixing them takes about three months from component order and roughly $15 million — on top of an unchanged $200 million first-phase capital expectation, and exclusive of it. The North Carolina facility has not been placed into service, which has in turn blocked drawdowns on the credit facility. The project has become a circular constraint: it needs money to run, and it can't borrow money until it runs. Meanwhile the unglamorous farmside build-out continues. Montauk has long-term agreements across more than 80 farming locations covering at least 400,000 hog spaces, with collection live on over 300,000. That is real progress against the target — and it is also feedstock the company is buying, drying and storing for a plant that is not yet converting it at scale.

The balance-sheet arithmetic

The liquidity plan reads like a triage list: defer “approximately $100 million-$120 million of development capital expenditures” — Kevin Van Asdalan, Chief Financial Officer · 2026-11-16, trim $10 million-$15 million of discretionary and uncommitted maintenance spending mostly from 2027, and draw up to $15 million of additional shareholder financing. Against that, unrestricted cash of roughly $12.4 million and receivables of $5.5 million. The trajectory that got here is visible in the filings. effective net cash has gone from a positive $34 million at the end of 2022 to negative $131 million, with a $27 million deterioration in just the last two quarters. Liabilities to assets has risen 10.4 percentage points year over year to 43.8%. And the cash engine has been running in reverse: free cash flow was negative $11 million last quarter against capital expenditures of $25 million. There is no self-funding path to the finish line here; the term sheet is the finish line.

Guidance trimmed, and a contradiction left standing

The full-year outlook keeps RNG volumes at 5.8-6.0 million MMBtu but narrows RNG revenue to $175-180 million from the $175-190 million reiterated in August — attributed to "decreased D3 RIN pricing." That sits awkwardly beside a quarter in which realized RIN prices rose 12.7% and the index rose 12.8%. The renewable electricity guide of $17-19 million is essentially an admission that Turkey contributes close to nothing this year, a full two-to-three quarters after management told investors to expect an EBITDA step-up from it. The legacy landfill portfolio is doing its job. McCarty produced 60,000 more MMBtu, Rumpke 42,000 more and Apex 26,000 more, offset by the Pico facility losing 30,000 MMBtu to digester maintenance and the familiar rhythm of media change-driven operating cost increases. RNG segment revenue rose 5.2% to $41.9 million. GreenWave kicked in $2.6 million of joint-venture income, with $2.1 million booked on 0.8 million distributed RINs sold. That environmental attribute revenue stream is genuine — but it is roughly $4 million a quarter of contribution against a nine-figure net debt position.

What the tape already believes

The stock is down about 90% from its 2022 peak of $20.32, down 60% from a $2.94 high set on September 29, and it lost more than half its value inside eight sessions. A price-to-revenue of roughly 1.2x, down 33% year over year, is no longer a growth multiple. It is an option premium on a successful forbearance negotiation and a functioning Turkey plant. One thing management did not say is worth noting. In the broader market, the RNG complex's live policy variable is the federal 45Z value credit — a theme that surfaced prominently in the last quarter's cross-market keyword set. Montauk's prepared remarks and Q&A do not lean on it, even as a valuation backstop. For a company whose binding constraint is now capital rather than RIN price, leaving an available tax-credit lever unmentioned is either prudence or a missed sentence — and investors will want to know which. What to watch: execution of the amendment (and whether the 12-month standstill becomes a longer restructuring), the arrival and burn rate of the $15 million shareholder financing, whether the moisture and syngas fixes actually hold commercial throughput, and whether 2027 capital deferrals start costing deposits and penalties as management flagged. The legacy RNG business is fine. Whether it remains equity in this company is now the question.